Search
for

    Sort by

    Research 541–570 of 1000+

    1. The Effect of 5 -Reductase Inhibitors on Erectile Function International Journal of Andrology · 2008 · 31 citations
    2. Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles Archives of Pharmacal Research · 2014 · 16 citations
    3. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men The Journal of Clinical Endocrinology and Metabolism · 1995 · 14 citations
    4. Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis British Journal of Dermatology · 1997 · 12 citations
    5. Finasteride: a 5 alpha-reductase inhibitor. PubMed · 1993 · 12 citations
    6. Is there a role for 5α‐reductase inhibitors in transgender individuals? International Journal of Andrology · 2020 · 10 citations
    7. 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level Medicinal Chemistry Research · 2010 · 7 citations
    8. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men. The Journal of Clinical Endocrinology and Metabolism · 1996 · 6 citations
    9. Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase Bioorganic & Medicinal Chemistry · 1997 · 5 citations
    10. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders. PubMed · 2013 · 3 citations
    11. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    12. Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond Journal of Chemical Crystallography · 2008 · 2 citations
    13. Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance Pharmaceuticals · 2026
    14. Inibição seletiva da 5α-redutase e preservação da aromatase no transplante capilar Revista Eletrônica Polidisciplinar Voos. · 2026
    15. Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia International Journal of Dermatology Venereology and Leprosy Sciences · 2026
    16. Finasteride and the 5-Alpha Reductase Inhibitors CRC Press eBooks · 2025
    17. 0192 Estrogenic effects of 5-alpha-reductase inhibitors in male androgenetic alopecia patients Journal of Investigative Dermatology · 2025
    18. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    19. Efficiency of 5% Minoxidil and Platelet-rich Plasma Therapy in Androgenetic Alopecia - A Retrospective Study Annals of Maxillofacial Surgery · 2025
    20. The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable? Uro-Technology Journal · 2024
    21. Efficacy and Safety of Topical 5% Azelaic Acid Solution Versus 2% Minoxidil Solution in the Treatment of Female Pattern Hair Loss Siriraj Medical Journal · 2023
    22. Crystal structure of Steroid 5-alpha-reductase 2 in complex with Finasteride 2020
    23. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study Journal of The American Academy of Dermatology · 2010 · 92 citations
    24. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men Advances in Experimental Medicine and Biology · 2017 · 31 citations
    25. Avicequinone C Isolated from Avicennia marina Exhibits 5α-Reductase-Type 1 Inhibitory Activity Using an Androgenic Alopecia Relevant Cell-Based Assay System Molecules · 2014 · 19 citations
    26. The Benefits of Dual Inhibition of 5α Reductase European Urology Supplements · 2006 · 4 citations
    27. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005 · 3 citations
    28. Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models Frontiers in Pharmacology · 2022 · 1 citations
    29. Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study Life · 2023
    30. Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty Endocrine journal · 2022